Last week's poll results: who should provide funding for large, randomized controlled drug trials? Most respondents (58%) chose the diplomatic answer and said that it should be a combination between government and pharmaceutical companies. I was somewhat surprised to note that more people felt that conducting RCTs should be the responsibility of the government (24%) rather than a responsibility of the pharmaceutical industry (only 7%), one of the most profitable industries within the U.S. currently.
Check out the new poll question of the week in the right margin.
No comments:
Post a Comment